Larrick JW - Search Results

1

Conference scene: progress with promising human antibodies.

Larrick JW. Larrick JW. Immunotherapy. 2012 Mar;4(3):257-61. doi: 10.2217/imt.12.5. Immunotherapy. 2012. PMID: 22401630

2

Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.

Larrick JW, Alfenito MR, Scott JK, Parren PW, Burton DR, Bradbury AR, Lemere CA, Messer A, Huston JS, Carter PJ, Veldman T, Chester KA, Schuurman J, Adams GP, Reichert JM. Larrick JW, et al. MAbs. 2016 Nov/Dec;8(8):1425-1434. doi: 10.1080/19420862.2016.1227665. Epub 2016 Aug 24. MAbs. 2016. PMID: 27557809 Free PMC article.

3

Antibody-membrane switch (AMS) technology for facile cell line development.

Yu B, Wages JM, Larrick JW. Yu B, et al. Among authors: larrick jw. Protein Eng Des Sel. 2014 Oct;27(10):309-15. doi: 10.1093/protein/gzu039. Epub 2014 Sep 14. Protein Eng Des Sel. 2014. PMID: 25225415

4

Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.

Larrick JW, Parren P, Huston JS, Plückthun A, Bradbury A, Tomlinson IM, Chester KA, Burton DR, Adams GP, Weiner LM, Scott JK, Alfenito MR, Veldman T, Reichert JM. Larrick JW, et al. MAbs. 2014;6(5):1115-23. doi: 10.4161/19420862.2014.971627. MAbs. 2014. PMID: 25517297 Free PMC article.

5

Fibroblast growth factor-21 is a promising dietary restriction mimetic.

Mendelsohn AR, Larrick JW. Mendelsohn AR, et al. Among authors: larrick jw. Rejuvenation Res. 2012 Dec;15(6):624-8. doi: 10.1089/rej.2012.1392. Rejuvenation Res. 2012. PMID: 23173578 Review.

6

Trade-offs between anti-aging dietary supplementation and exercise.

Mendelsohn AR, Larrick JW. Mendelsohn AR, et al. Among authors: larrick jw. Rejuvenation Res. 2013 Oct;16(5):419-26. doi: 10.1089/rej.2013.1484. Rejuvenation Res. 2013. PMID: 23998660

7

Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.

Parren PW, Burton DR, Bradbury A, Huston JS, Carter PJ, Veldman T, Chester KA, Larrick JW, Alfenito MR, Scott JK, Weiner LM, Adams GP, Reichert JM. Parren PW, et al. Among authors: larrick jw. MAbs. 2015;7(6):981-8. doi: 10.1080/19420862.2015.1089707. Epub 2015 Sep 30. MAbs. 2015. PMID: 26421752 Free PMC article.

8

Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.

Li B, Xu L, Tao F, Xie K, Wu Z, Li Y, Li J, Chen K, Pi C, Mendelsohn A, Larrick JW, Gu H, Fang J. Li B, et al. Among authors: larrick jw. Oncotarget. 2017 Jun 13;8(24):39356-39366. doi: 10.18632/oncotarget.17000. Oncotarget. 2017. PMID: 28454118 Free PMC article.

9

Prospects for the therapeutic use of human monoclonal antibodies.

Larrick JW, Bourla JM. Larrick JW, et al. J Biol Response Mod. 1986 Oct;5(5):379-93. J Biol Response Mod. 1986. PMID: 3534144 Review.

10

Production of antibodies in transgenic plants.

Larrick JW, Yu L, Chen J, Jaiswal S, Wycoff K. Larrick JW, et al. Res Immunol. 1998 Jul-Aug;149(6):603-8. doi: 10.1016/s0923-2494(98)80013-8. Res Immunol. 1998. PMID: 9835425 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results